Kaplan–Meier analysis revealed that lower ZGRF1 levels in tumor tissues were significantly correlated with increased overall survival (OS) rates in LUAD, PRAD, and the BRAF-like type of THCA cancers (Fig. 7M–O). The gene discussed is ZGRF1; the disease is prostate adenocarcinoma.